Study on chronic low-grade inflammation and influential factors of polycystic ovary syndrome

Medical Principles and Practice

Volumn 18, Issue 2, 2009, Pages 118-122

  Ruan, Xiangyan ^a   Dai, Yujie ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

Inflammation, low grade chronic; Insulin resistance; Polycystic ovarian syndrome; Triglycerides

Indexed keywords

C REACTIVE PROTEIN; GLYCOLIPID; INSULIN; SEX HORMONE; TRIACYLGLYCEROL;

ADULT; ARTICLE; CHINESE; CHRONIC INFLAMMATION; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HORMONE BLOOD LEVEL; HUMAN; INSULIN BLOOD LEVEL; INSULIN SENSITIVITY; LEUKOCYTE COUNT; LIPID METABOLISM; MAJOR CLINICAL STUDY; OVARY POLYCYSTIC DISEASE; PHYSICAL PARAMETERS; PROTEIN BLOOD LEVEL; TRIACYLGLYCEROL BLOOD LEVEL;

ADULT; C-REACTIVE PROTEIN; CHINA; CHRONIC DISEASE; FEMALE; HUMANS; INFLAMMATION; INSULIN RESISTANCE; LEUKOCYTE COUNT; LIPIDS; POLYCYSTIC OVARY SYNDROME; TESTOSTERONE;

EID: 60149089995     PISSN: 10117571     EISSN: None     Source Type: Journal    
DOI: 10.1159/000189809     Document Type: Article

References (25)

1. Essah PA, Wickham EP, Nestler JE: The metabolic syndrome in polycystic ovary syndrome. Clin Obstet Gynecol 2007;50:205-225.
2. Diamanti-Kandarakis E, Alexandraki K, Piperi C, Protogerou A, Katsikis I, Paterakis T, Lekakis J, Panidis D: Inflammatory and endothelial markers in women with polycystic ovary syndrome. Eur J Clin Invest 2006;36 691-697.
3. Möhlig M, Spranger J, Osterhoff M, Ristow M, Pfeiffer AF, Schill T, Schlösser HW, Brabant G, Schöfl C: The polycystic ovary syndrome per se is not associated with increased chronic inflammation. Eur J Endocrinol 2004;150:525-532.
4. Mayes JS, Watson GH: Direct effects of sex steroid hormones on adipose tissues and obesity. Obes Rev 2004;5:197-216.
5. Kitabchi AE, Imseis RE, Bush AJ, Williams-Cleaves B, Pourmotabbed G: Racial differences in the correlation between gonadal androgens and serum insulin levels. Diabetes Care 1999;22:1524-1529.
6. Kauffman RP, Baker VM, DiMarino P, Castracane VD: Hyperinsulinemia and circulating dehydroepiandrosterone sulfate in white and Mexican American women with polycystic ovary syndrome. Fertil Steril 2006;85:1010-1016.
7. Li L, Yang D, Chen X, Chen Y, Feng S, Wang L: Clinical and metabolic features of polycystic ovary syndrome. Int J Gynaecol Obstet 2007;97:129-134.
8. Miller M, Zhan M, Havas S: High attributable risk of elevated C-reactive protein level to conventional coronary heart disease risk factors: the Third National Health and Nutrition Examination. Arch Intern Med 2005;165:2063-2068.
9. The Rotterdam ESHRE/ASRM-Sponsored PCOS consensus workshop group: Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Hum Reprod 2004;19:41-47.
10. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC: Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985;28:412-419.
11. Boulman N, Levy Y, Leiba R, Shachar S, Linn R, Zinder O, Blumenfeld Z: Increased C-reactive protein levels in the polycystic ovary syndrome: a marker of cardiovascular disease. J Clin Endocrinol Metab 2004;89:2160-2165.
12. Kelly CC, Lyall H, Petrie JR, Gould GW, Connell JM, Sattar N: Low grade chronic inflammation in women with polycystic ovarian syndrome. J Clin Endocrinol Metab 2001;86:2453-2455.
13. Guerre-Millo M: Adipose tissue secretory function: implication in metabolic and cardiovascular complications of obesity. J Soc Biol 2006;200:37-43.
14. Berg AH, Scherer PE: Adipose tissue, inflammation, and cardiovascular disease. Circ Res 2005;96:939-949.
15. Ahmad I, Zhan M, Miller M: High prevalence of C-reactive protein elevation with normal triglycerides (100-149 mg/dL): are triglyceride levels below 100 mg/dL more optimal in coronary heart disease risk assessment? Am J Med Sci 2005;329:173-177.
16. Kawakami A, Aikawa M, Nitta N, Yoshida M, Libby P, Sacks FM: Apolipoprotein CIII-induced THP-1 cell adhesion to endothelial cells involves pertussis toxin-sensitive G protein- and protein kinase C alpha-mediated nuclear factor-kappaB activation. Arterioscler Thromb Vasc Biol 2007;27:219-225.
17. Puder JJ, Varga S, Kraenzlin M, De Geyter C, Keller U, Müller B: Central fat excess in polycystic ovary syndrome: relation to low-grade inflammation and insulin resistance. J Clin Endocrinol Metab 2005;90:6014-6021.
18. Connelly PW, Hanley AJ, Harris SB, Hegele RA, Zinman B: Relation of waist circumference and glycemic status to C-reactive protein in the Sandy Lake Oji-Cree. Int J Obes Relat Metab Disord 2003;27:347-354.
19. Snell-Bergeon JK, Hokanson JE, Kinney GL, Dabelea D, Ehrlich J, Eckel RH, Ogden L, Rewers M: Measurement of abdominal fat by CT compared to waist circumference and BMI in explaining the presence of coronary calcium. Int J Obes Relat Metab Disord 2004;28:1594-1599.
20. Albu JB, Kovera AJ, Allen L, Wainwright M, Berk E, Raja-Khan N, Janumala I, Burkey B, Heshka S, Gallagher D: Independent association of insulin resistance with larger amounts of intermuscular adipose tissue and a greater acute insulin response to glucose in African American than in white nondiabetic women. Am J Clin Nutr 2005;82:1210-1217.
21. Blight LF, Judd SJ, White GH: Relative diagnostic value of serum non-SHBG-bound testosterone, free androgen index and free testosterone in the assessment of mild to moderate hirsutism. Ann Clin Biochem 1989;26:311-316.
22. Sowers MR, Jannausch M, Randolph JF, Mc-Connell D, Little R, Lasley B, Pasternak R, Sutton-Tyrrell K, Matthews KA: Androgens are associated with hemostatic and inflammatory factors among women at the midlife. J Clin Endocrinol Metab 2005;90:6064-6071.
23. Joffe HV, Ridker PM, Manson JE, Cook NR, Buring JE, Rexrode KM: Sex hormone-binding globulin and serum testosterone are inversely associated with C-reactive protein levels in postmenopausal women at high risk for cardiovascular disease. Ann Epidemiol 2006;16:105-112.
24. Wang Q, Hunt SC, Xu Q, Chen YE, Province MA, Eckfeldt JH, Pankow JS, Song Q: Association study of CRP gene polymorphisms with serum CRP level and cardiovascular risk in the NHLBI Family Heart Study. Am J Physiol Heart Circ Physiol 2006;291:H2752-H2757.
25. Nicklas BJ, You T, Pahor M: Behavioural treatments for chronic systemic inflammation: effects of dietary weight loss and exercise training. CMAJ 2005;172:1199-1209.